• 한국동물위생학회지
• /
• 제43권3호
• /
• pp.139-145
• /
• 2020

This study was carried out to identify the occurrence of transovarian transmitted diseases and antibody positive rates among Korean native breeder chickens. The infection rates with Salmonella pullorum and Salmonella gallinarum among 16-week-old, 36-week-old, and 56-week-old breeder chickens and the antibody positive rates to Egg Drop Syndrome '76, Mycoplasma gallisepticum and Mycoplasma synoviae among 16-week-old, 18-week-old, and 56-week-old breeder chickens were identified, and the antibody positive rates to seven major transovarian transmitted diseases among 1-day-old chicks were investigated. As a result, no infection with Salmonella pullorum and Salmonella gallinarum was found among the investigated subjects of all ages. Vaccinated breeder chickens showed the 100% antibody positive rate to Egg Drop Syndrome '76, and unvaccinated breeder chickens showed the 100% antibody negative rate to Mycoplasma gallisepticum and Mycoplasma synoviae, confirming that there was no infection with Mycoplasma gallisepticum and Mycoplasma synoviae. As a result of the antibody tests of the 1-day-old chicks for transovarian transmitted diseases, it was found that vaccinated chicks showed good antibody positive rates to avian encephalomyelitis, chicken infectious anemia, and avian reovirus, confirming that they had power of defense against the relevant infectious diseases, and that unvaccinated chicks showed the 100% antibody negative rates to avian leukosis, chicken reticuloendotheliosis, and Mycoplasma synoviae, confirming that there was no infection with the relevant diseases. Given that the results of this study showed that among the transovarian transmitted diseases of chickens, there was no history of infection with diseases against which vaccination was not administered and high antibody positive rates were found with diseases against which vaccination was administered, it is judged that chickens with good power of defense against diseases were bred, and it is deemed that constant monitoring and vaccination against transovarian transmitted diseases will be necessary for the control and prevention of the diseases.

• IMMUNE NETWORK
• /
• 제1권2호
• /
• pp.116-125
• /
• 2001

Background: Nitric oxide (NO) production has been described as a double-edged sword eliciting both pro- and anti-inflammatory effects in different immune reactions. This work was undertaken to investigate the immunoregulatory role of NO in experimental allergic encephalomyelitis (EAE) and experimental allergic uveitis (EAU). Method: We examined whether molsidomine (MSDM), a NO donor, administration to the myelin basic protein (MBP)- or interphotoreceptor retinoid binding protein (IRBP)-immunized rats could suppress EAE development by shifting toward the Th2 cytokine response. In the EAE experiments, the rats were treated orally with MSDM (10 mg/kg/day) at the early stage (-1~4 days) or throughout the experimental period (-1~15 days). Results: This resulted in significant amelioration of the disease and mild clinical symptoms, while MBP-immunization without MSDM administration showed severe EAE development. A marked reduction in inflammation was also observed in the spinal cord, indicating the crucial role of NO in the pathogenesis of EAE in in vivo. In the EAU experiments, a 24 h pre-treatment with MSDM prior to IRBP immunization resulted in significant inhibition of the disease. Furthermore, MSDM administration for 2 1 days completely reduced the incidence and severity of EAU. To investigate whether MSDM could modulate cytokine switching from Th 1 to Th2, culture supernatants of MBP- or IRBP-stimulated inguinal lymphocytes were analyzed. MSDM treatment enhanced IL-10 secretion but decreased IFN-${\gamma}$. IL-4 was undetectable in all groups. In contrast, the MBP-or IRBP-immunized rats without MSDM secreted high concentrations of IFN-${\gamma}$, but low concentrations of IL-10. Conclusion: In conclusion, NO administation suppresses EAE and EAU by modulating the Th1/Th2 balance during inflammatory immune responses. This work further suggests that NO may be useful in the therapeutic control of autoimmune disease.

• 대한수의학회지
• /
• 제26권1호
• /
• pp.87-92
• /
• 1986

The present surveys were conducted in attempts to investigate the health situation of horses in Korea through mass-screening the samples serologically, bacteriologically and clinically. A total of 575 horses were sampled randomly, comprising 126 from the Korean Horse Affairs Association, 288 from the Korean Equestrian Federation and 161 from the Jeju ponies. Each of the samples taken was tested for diagnoses of 18 horse diseases including African horse sickness. Summarised below are the results obtained from this surveys. 1. From results of the serological survey it is evident that Korea is currently free from African horse sickness, dourine, glanders, vesicular stomatits, equine piroplasmosis, equine viral arteritis, Venezuelan encephalomyelitis and contagious equine metritis. Constant vigilence with strengthened quarantine measures is thus vital for maintaining freedom of any those diseases in Korea. 2. No clinical case was observed with any of signs or symptoms of infectious lymphangitis, anthrax and infestations with ringworm, mange or scab. However, continuous follow-up is required for establishing the evidence of no occurrence of the diseases in Korea. 3. One case of seropositive to equine infectious anemia may fully justify systematic and regular testings for the whole population of horse in Korea. 4. It is manifested that equine rhinopneumonitis, Japanese encephalitis and Getah virus infection are well established in Korea, together with the presence of equine infectious abortion(Salmonella abortus equi). This strongly entails preventive precautions before entry into Korea for the horses participating in the 1986 Asian Games and the 1988 Seoul Olympics.

• IMMUNE NETWORK
• /
• 제3권4호
• /
• pp.302-309
• /
• 2003

Background: CTLA4 (CD152), which is expressed on the surface of T cells following activation, has a much higher affinity for B7 molecules comparing to CD28, and is a negative regulator of T cell activation. In contrast to stimulating and agonistic capabilities of monoclonal antibodies specific to CTLA-4, CTLA4Ig fusion protein appears to act as CD28 antagonist and inhibits in vitro and in vivo T cell priming in variety of immunological conditions. We've set out to confirm whether inhibition of the CD28-B7 costimulatory response using a soluble form of human CTLA4Ig fusion protein would lead to persistent inhibition of alloreactive T cell activation. Methods: We have used CHO-$dhfr^-$ cell-line to produce CTLA4Ig fusion protein. After serum free culture of transfected cell line we purified this recombinant molecule by using protein A column. To confirm characterization of fusion protein, we carried out a series of Western blot, SDS-PAGE and silver staining analyses. We have also investigated the efficacy of CTLA4Ig in vitro such as mixed lymphocyte reaction (MLR) & cytotoxic T lymphocyte (CTL) response and in vivo such as experimental autoimmune encephalomyelitis (EAE), graft versus host disease (GVHD) and skin-graft whether this fusion protein could inhibit alloreactive T cell activation and lead to immunosuppression of activated T cell. Results: In vitro assay, CTLA4Ig fusion protein inhibited immune response in T cell-specific manner: 1) Human CTLA4Ig inhibited allogeneic stimulation in murine MLR; 2) CTLA4Ig prevented the specific killing activity of CTL. In vivo assay, human CTLA4Ig revealed the capacities to induce alloantigen-specific hyporesponsiveness in mouse model: 1) GVHD was efficiently blocked by dose-dependent manner; 2) Clinical score of EAE was significantly decreased compared to nomal control; 3) The time of skin-graft rejection was not different between CTLA4Ig treated and control group. Conclusion: Human CTLA4Ig suppress the T cell-mediated immune response and efficiently inhibit the EAE, GVHD in mouse model. The mechanism of T cell suppression by human CTLA4Ig fusion protein may be originated from the suppression of activity of cytotoxic T cell. Human CTLA4Ig could not suppress the rejection in mouse skin-graft, this finding suggests that other mechanism except the suppression of cytotoxic T cell may exist on the suppression of graft rejection.

• 대한바이러스학회지
• /
• 제27권1호
• /
• pp.39-47
• /
• 1997

A large number of viruses belonging to Genus Hantavirus in Family Bunyaviridae are etiologic agents for hemorrhagic fever with renal syndrome (HFRS), or hantavirus pulmonary syndrome (HPS). Hantaan (HTN), Seoul (SED), Belgrade (BEL), Puumala (PUU) serotype viruses are well known causative agents for HFRS in Eurasian continent. Among those viruses Hantaan and Seoul serotypes are well known to cause HFRS in Korea, but there are some sporadic incidence by other than Hantaan or Seoul viruses. Recently we have developed the combined Hantaan-Puumala virus vaccine to prevent world-wide occuring HFRS. This combined vaccine is formalin inactivated, suckling mouse and suckling hamster brain extracts for Hantaan and Puumala viruses, respectively. Protein contents of this purified candidate vaccine is $27\;{\mu}g/ml$, which contains 1,024 ELISA antigen units to each virus, but content of myelin basic protein which is causing experimental allergic encephalomyelitis is less than 0.1 ng/ml. Thirty hamsters were given twice at one month interval intra-muscularly and bled on 30 days after each vaccination from retro-orbital sinus vein. Antibody titers were tested against 5 major serotype viruses, Hantaan, Seoul, Belgrade, Puumala and Sin Nombre viruses by IFA and PRNT. The mean IF antibody titers on 30 days after primary shot were 78.4, 68.8, 68.8, 37.9, and 15.6; mean neutralizing antibody titers were 65.4, 12, 6.1, 65.6 and 0.5 against Hantaan, Seoul, Belgrade, Puumala and Sin Nombre viruses, respectively. The mean IF antibody titers on 30 days after booster shot were 686.9, 567.5, 550.4, 516.3, and 430.9; and neutralizing antibody titers were 710.8, 41.9, 24.3, 409.9, and 1.6 against Hantaan, Seoul, Belgrade, Puumala and Sin Nombre viruses, respectively.

• 한국가금학회지
• /
• 제16권3호
• /
• pp.175-192
• /
• 1989

한국 양계의 성장기이었던 1971년부터 1988년까지 최근 18연간 국내 양계농가로부터 농촌진흥청 가축위생연구소에 의뢰된 닭 가검물의 병성감정결과 질병검색된 총 9,012건 중 전염성 질병으로 진단된 6,181건에 대하여 검색 연도별, 계절별 및 일영별 검색상황을 조사 분석하였던 바 다음과 같은 결과를 얻었다. 1. 연도별 전염성 질병의 검색률은 49.3％(1973연)∼78.3％(1985년)로써 연평균 68.6％로 나타나 비전염성 질병(31.42％)보다는 월등히 높았다. 2. 전염성 질병 중에는 세균성이 32.6％(16.2∼42.5％)로 가장 높았고 다음 바이러스성 질병이 26.3％(21.8∼38.1％)이었으며 기생충성 및 곰팡이성 질병은 각각 7.7％ 및 2.1％의 낮은 검색율을 나타내었다. 3. 세균성 질병으로는 마이코프라스마병, 대장균증 및 포도상구균증의 연평균검색률이 각각 8.8％, 8.5％, 5.8％로 가장 높았으며, 다음 살모넬라균증, 추백리, 난황염 및 수란괌염이 각각 0.8∼1.5％ 이었고 피부염(0.2％) 및 연쇄상구균증(0.1％)은 매우 낮은 빈도로 검색되었다. 4. 바이러스성 질병중에는 임파성 백혈병 및 마렉병이 각각 연평균 7.5％ 및 7.2％로 가장 많았고 다음 뉴캣슬병(4.4％), 전염성 후두기관염(2.0％), 전염성 낭병(1. 7％) 및 조뇌척수염(1.0％)의 순이었으며 그 외 전염성 기관지염, 산란저하증 '76 및 봉입체간염 등이 각각 1.0％, 미만으로 검색되었다. 5. 기생충성 질병의 검색률에 있어서는 닭 콕시듐병이 연평균 4.5％로 가장 높았고 다음 회염증이 1.4％이었다. 그 외에 류코싸이토준병 흑두병, 맹장충증 및 외부기생충증이 각각 0.2∼0.7％의 낮은 비율로 검색되었다. 곰팡이성 질병으로는 곰팡이성 폐렴이 연평균 2.0％, 다음으로 캔디다증이 0.1％ 검색되었다. 6. 계절별 전염성 질병의 검색은 하계 및 추계절에 각각 27.7％ 검색되어 가장 높았으며 다음 동계(23.5％) 및 춘계절의 순으로 낮았다. 이들중 세균성, 바이러스성 및 곰팡이성 질병은 이와 유사한 경향이었으나 기생충성 질병은 하계 및 추계절에서의 검색률이 각각 34.3％ 및 39.5％로 다른 계절에 비하여 월등히 높았다. 7. 세균성 포도장구균증은 추계절에서의 검색율이 가장 높았으며, 바이러스성 질병으로는 마렉병, 전염성 후두기관염 및 전염성 낭병은 하계절에, 그리고 임파성백혈병, 계두 및 산란저하증 '76은 추계절에서 가장 높았으며 전염성 기관지염은 동계절에 최고빈도로 검색되었다. 기생충성 질병에 있어서는 콕시듐병을 위시하여 회충증, 류코싸이토준병 및 흑두병등 대부분의 주요질병이 하계절 및 추계절에 가장 많이 검색되었다. 8. 닭 일영별 전염성 질병의 검색률은 육성계(30∼150일영)에서 47.4％의 가장 높은 검색률을 나타내었고 다음 성계(150일영이상)에서 35.3％ 및 유추(30 일영미만)에서 17.3％의 순이었다. 이중 세균성 및 기생충성 질병은 육성계에서의 검색률이 가장 높았으나, 바이러스성 질병은 육성계 및 성계에서 거의 같은 비율로 높았으며 곰팡이성 질병은 유추에서 가장 높은 검색률을 나타내었다.